Product Details
Apretude 30 mg film coated tablets*
Cabotegravir30 mg
Film coated tablet
ROA
Oral
Applicant Name
Glaxo Smithkline Consumer Nigeria PLC
NRN
A4-100536
Status
Active
Composition
ATC Code
J05AJ04
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
30
Product Description
30 NF-PP-335435 Apretude 30 mg film coated tablets Cabotegravir cabotegravir 30 mg, Lactose Monohydrate Microcystalline Cellulose Hypromellose (E464) Sodium Starch Glycolate (Type A) Magnesium Stearate, Hypromellose (E464) Titanium Dioxide (E171), Macrogol 400 (E1521) Drugs Imported Products 30 Prescription Only Medicine (POM) 6/22/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 regulatorypharma-ng@gsk.com Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations), Priory Street Ware Hertfordshire SG12 0DJ UK, United Kingdom
Manufacturer Name
Glaxo Operations UK Limited
Manufacturer Country
UNITED KINGDOM
Approval Date
2023-09-28
Expiry Date
2028-09-27